- Home
- NINE vs OCX Comparison
NINE vs OCX Comparison
Compare NINE & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NINE
- OCX
- Stock Information
- Founded
- NINE 2011
- OCX 2009
- Country
- NINE United States
- OCX United States
- Employees
- NINE N/A
- OCX N/A
- Industry
- NINE Oilfield Services/Equipment
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NINE Energy
- OCX Health Care
- Exchange
- NINE Nasdaq
- OCX Nasdaq
- Market Cap
- NINE 38.9M
- OCX 38.7M
- IPO Year
- NINE 2018
- OCX N/A
- Fundamental
- Price
- NINE $1.00
- OCX $2.23
- Analyst Decision
- NINE
- OCX Buy
- Analyst Count
- NINE 0
- OCX 3
- Target Price
- NINE N/A
- OCX $4.42
- AVG Volume (30 Days)
- NINE 1.2M
- OCX 123.4K
- Earning Date
- NINE 10-31-2024
- OCX 11-12-2024
- Dividend Yield
- NINE N/A
- OCX N/A
- EPS Growth
- NINE N/A
- OCX N/A
- EPS
- NINE N/A
- OCX N/A
- Revenue
- NINE $556,751,000.00
- OCX $709,000.00
- Revenue This Year
- NINE N/A
- OCX N/A
- Revenue Next Year
- NINE $2.93
- OCX $106.34
- P/E Ratio
- NINE N/A
- OCX N/A
- Revenue Growth
- NINE N/A
- OCX N/A
- 52 Week Low
- NINE $0.75
- OCX $1.98
- 52 Week High
- NINE $3.26
- OCX $3.82
- Technical
- Relative Strength Index (RSI)
- NINE 39.45
- OCX 30.62
- Support Level
- NINE $0.96
- OCX $2.18
- Resistance Level
- NINE $1.87
- OCX $2.36
- Average True Range (ATR)
- NINE 0.13
- OCX 0.15
- MACD
- NINE -0.06
- OCX -0.01
- Stochastic Oscillator
- NINE 12.64
- OCX 41.07
About NINE Nine Energy Service Inc.
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.